[1] ROTHG A, MENSAH G A, JOHNSON C O, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study[J].J Am Coll Cardiol, 2020, 76(25): 2982-3021. [2] LEWISS J. Cardiovascular disease in postmenopausal women: myths and reality[J].Am J Cardiol, 2002, 89(12A): 5E-10E;discussion10E-11E. [3] HUANG Y, LIU Y, MA Y, et al. Associations of visceral adipose tissue, circulating protein biomarkers, and risk of cardiovascular diseases: a mendelian randomization analysis[J].Front Cell Dev Biol, 2022, 10: 840866. [4] BEYDOUNM A, WANG Y. Gender-ethnic disparity in BMI and waist circumference distribution shifts in US adults[J].Obesity, 2009, 17(1): 169-176. [5] D’AGOSTINO R B, PENCINAM J, MASSARO J M, et al. Cardiovascular disease risk assessment: insights from Framingham[J].Glob Heart, 2013, 8(1): 11-23. [6] VOGEL B, ACEVEDO M, APPELMAN Y, et al. The Lancet Women and Cardiovascular Disease Commission: reducing the global burden by 2030[J].Lancet, 2021, 397(10292): 2385-2438. [7] LI Y, HE Y, YANG L, et al. Body roundness index and waist-hip ratio result in better cardiovascular disease risk stratification: results from a large Chinese cross-sectional study[J].Front Nutr, 2022, 9: 801582. [8] WU Q, ZHANG F, LI R, et al. Identification of the best anthropometric index for predicting the 10-year cardiovascular disease in southwest China: a large single-center, cross-sectional study[J].High Blood Press Cardiovasc Prev, 2022, 29(5): 417-428. [9] BRAND J S, VAN DER SCHOUW Y T. Testosterone, SHBG and cardiovascular health in postmenopausal women[J].Int J Impot Res, 2010, 22(2): 91-104. [10]EL KHOUDARYS R, AGGARWAL B, BECKIE T M, et al. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American heart association[J].Circulation, 2020, 142(25): e506-e532. [11]XU Z, GU S, WU X, et al. Association of follicle stimulating hormone and serum lipid profiles in postmenopausal women[J].Medicine, 2022, 101(39): e30920. [12]EL KHOUDARYS R. HDL and the menopause[J].Curr Opin Lipidol, 2017, 28(4): 328-336. [13]GOLASZEWSKIN M, LACROIX A Z, GODINO J G, et al. Evaluation of social isolation, loneliness, and cardiovascular disease among older women in the US[J].JAMA Netw Open, 2022, 5(2): e2146461. [14]RICO-MARTÍN S, CALDERÓN-GARCÍAJ F, SÁNCHEZ-REY P, et al. Effectiveness of body roundness index in predicting metabolic syndrome: a systematic review and meta-analysis[J].Obes Rev, 2020, 21(7): e13023. [15]LI G, WUH K, WU X W, et al. The feasibility of two anthropometric indices to identify metabolic syndrome, insulin resistance and inflammatory factors in obese and overweight adults[J].Nutrition, 2019, 57: 194-201. [16]LI G, YAO T, WUX W, et al. Novel and traditional anthropometric indices for identifying arterial stiffness in overweight and obese adults[J].Clin Nutr, 2020, 39(3): 893-900. [17]ZHANG S, HAN S, ZHENG L, et al. Associations of trajectories in body roundness index with incident cardiovascular disease: a prospective cohort study in rural China[J].Front Nutr, 2024, 11: 1291093. [18]XU J, ZHANG L, WU Q, et al. Body roundness index is a superior indicator to associate with the cardio-metabolic risk: evidence from a cross-sectional study with 17, 000 Eastern-China adults[J].BMC Cardiovasc Disord, 2021, 21(1): 97. [19]XUE R, LI Q, GENG Y, et al. Abdominal obesity and risk of CVD: a dose-response meta-analysis of thirty-one prospective studies[J].Br J Nutr, 2021, 126(9): 1420-1430. [20]MESERI R, UCKU R, UNAL B. Waist: height ratio: a superior index in estimating cardiovascular risks in Turkish adults[J].Public Health Nutr, 2014, 17(10): 2246-2252. [21]CHENB D, HE C H, MA Y T, et al. Best anthropometric and atherogenic predictors of metabolic syndrome in the Chinese Han population in Xinjiang: the Cardiovascular Risk Survey[J].Ann Nutr Metab, 2014, 65(4): 280-288. [22]FAN H, LI X, ZHENG L, et al. Abdominal obesity is strongly associated with cardiovascular disease and its risk factors in elderly and very elderly community-dwelling Chinese[J].Sci Rep, 2016, 6: 21521. [23]YU J, TAO Y, TAO Y, et al. Optimal cut-off of obesity indices to predict cardiovascular disease risk factors and metabolic syndrome among adults in Northeast China[J].BMC Public Health, 2016, 16(1): 1079. [24]National Institute for Health and Care Excellence(NICE). Obesity: identification, assessment and management.[EB/OL].(2023-07-26)[2024-05-10].https://www.nice.org.uk/guidance/cg189. [25]FENG Q, BEŠEVIĆ J, CONROY M, et al. Waist-to-height ratio and body fat percentage as risk factors for ischemic cardiovascular disease: a prospective cohort study from UK Biobank[J].Am J Clin Nutr, 2024, 119(6): 1386-1396. [26]ISLAMM T, CHOWDHURY A T, SIRAJ M S, et al. Anthropometric indices in predicting 10-year cardiovascular risk among males and females aged 40-74 years in south and Southeast Asia: analysis of 12 WHO STEPS survey data[J].Lancet Reg Health Southeast Asia, 2024, 29: 100481. [27]PAAJANENT A, OKSALA N K J, KUUKASJÄRVI P, et al. Short stature is associated with coronary heart disease: a systematic review of the literature and a meta-analysis[J].Eur Heart J, 2010, 31(14): 1802-1809. [28]HENRIKSSONK M, LINDBLAD U, AGREN B, et al. Associations between body height, body composition and cholesterol levels in middle-aged men. The coronary risk factor study in southern Sweden(CRISS)[J].Eur J Epidemiol, 2001, 17(6): 521-526. |